You are here

Development and Validation for Taiwan Version ID Pain Questionnaire (ID Pain-T) and DN4 Questionnaire.

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Neuralgia, Nerve Pain, Neuropathic Pain
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Subjects without headache pain over 30 days and at least 18 years old who will visit
the clinic, inclusive of male and female.

- Subjects who are able to complete the ID Pain-T Questionnaire.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects who are illiterate or unable to complete questionnaire.

- Subjects who are currently participating in another study or have participated in
another pain study within one month of study entry.

- Subjects with low back pain are unable to participate in this study; as the sciatica
caused by the piriformis (exclusive of the other types of sciatic pain), lumbago,
unclear identification in nerve injury (e.g. complex regional pain syndrome type I) or
mixed origin (e.g. cancer pain).

NCT00599768
Pfizer
Completed
Development and Validation for Taiwan Version ID Pain Questionnaire (ID Pain-T) and DN4 Questionnaire.

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now